← Open Payments lookup

ROBERT POLK: Open Payments

NPI 1982287314 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$873 in 31 payments from 9 companies in 2025. Trend: 2023 $3,125 · 2024 $2,750 · 2025 $873

Food & beverage: $873
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$196
Teva Pharmaceuticals USA, Inc.6$162
Neurocrine BioSciences, Inc.4$106
ABBVIE INC.4$93
Axsome Therapeutics, Inc.2$90
Otsuka America Pharmaceutical, Inc.4$79
Janssen Pharmaceuticals, Inc2$70
E.R. Squibb & Sons, L.L.C.3$58
Alkermes, Inc.1$20

Products named: CAPLYTA, AUSTEDO XR, INGREZZA, VRAYLAR, Auvelity, SPRAVATO, COBENFY, REXULTI.

Industry payments across TX — which companies pay providers there.